M28 Capital Management LP Takes 5.0% Stake in Curis Inc.
Ticker: CRIS · Form: SC 13G · Filed: Feb 12, 2024 · CIK: 1108205
| Field | Detail |
|---|---|
| Company | Curis INC (CRIS) |
| Form Type | SC 13G |
| Filed Date | Feb 12, 2024 |
| Risk Level | low |
| Pages | 5 |
| Reading Time | 6 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, passive-investment, stake-disclosure
TL;DR
**M28 Capital Management LP just disclosed a 5.0% stake in Curis, Inc. as of year-end 2023.**
AI Summary
M28 Capital Management LP, a Delaware-based investment firm, reported owning 421,951 shares of Curis, Inc. common stock as of December 31, 2023. This represents a 5.0% stake in the biotechnology company, triggering an SC 13G filing because their ownership crossed the 5% threshold. This matters to investors because M28 Capital Management LP is now a significant shareholder, and their future actions could influence Curis's stock price and strategic decisions.
Why It Matters
A new institutional investor, M28 Capital Management LP, now holds a notable stake in Curis, Inc., signaling potential confidence in the company's future or a strategic move that could impact its direction.
Risk Assessment
Risk Level: low — This filing indicates a new institutional investor, which is generally a positive or neutral development for existing shareholders.
Analyst Insight
Smart investors should note the entry of M28 Capital Management LP as a significant shareholder and monitor any future filings (like Schedule 13D if they become activist) or news regarding their involvement with Curis, Inc. to gauge potential strategic shifts or increased institutional confidence.
Key Numbers
- 421,951 — Shares Beneficially Owned (The total number of Curis, Inc. shares M28 Capital Management LP now controls.)
- 5.0% — Ownership Percentage (This percentage signifies M28 Capital Management LP's significant stake in Curis, Inc., triggering the SC 13G filing.)
- December 31, 2023 — Event Date (The specific date when M28 Capital Management LP's ownership crossed the threshold requiring this disclosure.)
Key Players & Entities
- M28 Capital Management LP (company) — the reporting person and new significant shareholder
- Curis, Inc. (company) — the subject company whose shares were acquired
- Delaware (company) — place of organization for M28 Capital Management LP
- 421,951 (dollar_amount) — number of shares beneficially owned by M28 Capital Management LP
- 5.0% (dollar_amount) — percentage of Curis, Inc. common stock owned by M28 Capital Management LP
- December 31, 2023 (person) — date of the event which required the filing
Forward-Looking Statements
- M28 Capital Management LP will maintain or increase its stake in Curis, Inc. over the next 6-12 months. (M28 Capital Management LP) — medium confidence, target: December 31, 2024
FAQ
Who is the reporting person in this SC 13G filing?
The reporting person is M28 Capital Management LP, a company organized in Delaware.
What is the subject company whose shares were acquired?
The subject company is Curis, Inc., a biotechnology company with a business address in Lexington, MA.
How many shares of Curis, Inc. common stock does M28 Capital Management LP beneficially own?
M28 Capital Management LP beneficially owns 421,951 shares of Curis, Inc. common stock.
What percentage of Curis, Inc.'s common stock does M28 Capital Management LP own?
M28 Capital Management LP owns 5.0% of Curis, Inc.'s common stock, calculated as 421,951 shares out of the total outstanding shares.
What was the date of the event that triggered this SC 13G filing?
The date of the event which required the filing of this statement was December 31, 2023.
Filing Stats: 1,491 words · 6 min read · ~5 pages · Grade level 9.6 · Accepted 2024-02-12 16:16:14
Key Financial Figures
- $0.01 — Inc. (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of
Filing Documents
- p24-0363sc13g.htm (SC 13G) — 65KB
- 0000902664-24-001427.txt ( ) — 66KB
(a)
Item 1(a). NAME OF ISSUER: The name of the issuer is Curis, Inc. (the " Company ").
(b)
Item 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: The Company's principal executive offices are located at 128 Spring Street, Building C, Suite 500, Lexington, MA 02421.
(a)
Item 2(a). NAME OF PERSON FILING: This statement is filed by: (i) M28 Capital Management LP (" M28 Capital ") with respect to the shares of Common Stock (as defined in Item 2(d)) held by M28 Capital Master Fund LP (the " M28 Fund ") to which it acts as investment manager; and (ii) Marc Elia, the Chief Investment Officer of M28 Capital and Managing Member of M28 Capital Management GP LLC, the general partner of M28 Capital (" Mr. Elia ", together with M28 Capital and M28 Capital Management GP, LLC, the " M28 Parties "), with respect to the shares of Common Stock held by the M28 Fund. Each of the foregoing is referred to as a " Reporting Person " and collectively as the " Reporting Persons ." The filing of this statement should not be construed as an admission that any of the foregoing persons or any Reporting Person is, for the purposes of Section 13 of the Act, the beneficial
(b)
Item 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: The principal business address of each of the M28 Parties is 700 Canal Street, 2nd Floor, Stamford, CT 06902.
(c)
Item 2(c). CITIZENSHIP: M28 Capital is a Delaware limited partnership. Mr. Elia is a United States citizen.
(d)
Item 2(d). TITLE OF CLASS OF SECURITIES: Common stock, $0.01 par value per share (the " Common Stock ").
(e)
Item 2(e). CUSIP NUMBER: 231269309 CUSIP No. 231269200 13G Page 5 of 7 Pages Item 3. IF THIS STATEMENT IS FILED PURSUANT TO §§ 240.13d-1(b) OR 240.13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A: (a) ¨ Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o); (b) ¨ Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c); (c) ¨ Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c); (d) ¨ Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); (e) x Investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); (f) ¨ Employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); (g) x Parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); (h) ¨ Savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) ¨ Church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3); (j) ¨ Non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J); (k) ¨ Group, in accordance with Rule 13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J), please specify the type of institution:___________________________________________ Item 4. The information required by Items 4(a) - (c) is set forth in Rows 5 - 11 of the cover page for each of the Reporting Persons hereto and is incorporated herein by reference for each of the Reporting Persons. The percentages used in this Schedule 13G are calculated based upon 5,894,085 shares of Common Stock outstanding as of December 18, 2023, as reported in Amendment No. 1 to the Company's Annual Report on Form 10-K/A for the fiscal year ended December 31, 2022, filed with the Securities and Exchange Commission on December 2
SIGNATURES
SIGNATURES After reasonable inquiry and to the best of our knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct. DATED: February 12, 2024 M28 Capital Management LP /s/ Christopher M. Taliercio Christopher M. Taliercio, President and Chief Compliance Officer /s/ Marc Elia MARC ELIA Exhibit 99.1 JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate. DATED: February 12, 2024 M28 Capital Management LP /s/ Christopher M. Taliercio Christopher M. Taliercio, President and Chief Compliance Officer /s/ Marc Elia MARC ELIA